Vanguard Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.09B | Sell |
|
|||||
|
2025
Q2 | $4.95B | Buy |
|
|||||
|
2025
Q1 | $5.97B | Buy |
|
|||||
|
2024
Q4 | $6.61B | Sell |
|
|||||
|
2024
Q3 | $9.8B | Buy |
|
|||||
|
2024
Q2 | $9.45B | Buy |
|
|||||
|
2024
Q1 | $8.6B | Buy |
|
|||||
|
2023
Q4 | $7.76B | Buy |
|
|||||
|
2023
Q3 | $7.24B | Sell |
|
|||||
|
2023
Q2 | $6.36B | Buy |
|
|||||
|
2023
Q1 | $7.27B | Buy |
|
|||||
|
2022
Q4 | $6.29B | Buy |
|
|||||
|
2022
Q3 | $5.96B | Buy |
|
|||||
|
2022
Q2 | $5.07B | Buy |
|
|||||
|
2022
Q1 | $5.84B | Buy |
|
|||||
|
2021
Q4 | $5.15B | Buy |
|
|||||
|
2021
Q3 | $4.88B | Buy |
|
|||||
|
2021
Q2 | $4.45B | Sell |
|
|||||
|
2021
Q1 | $3.79B | Buy |
|
|||||
|
2020
Q4 | $3.83B | Sell |
|
|||||
|
2020
Q3 | $4.47B | Buy |
|
|||||
|
2020
Q2 | $4.89B | Buy |
|
|||||
|
2020
Q1 | $3.13B | Buy |
|
|||||
|
2019
Q4 | $2.35B | Buy |
|
|||||
|
2019
Q3 | $1.72B | Buy |
|
|||||
|
2019
Q2 | $1.9B | Buy |
|
|||||
|
2019
Q1 | $2.47B | Buy |
|
|||||
|
2018
Q4 | $2.2B | Buy |
|
|||||
|
2018
Q3 | $2.33B | Buy |
|
|||||
|
2018
Q2 | $1.96B | Buy |
|
|||||
|
2018
Q1 | $1.93B | Buy |
|
|||||
|
2017
Q4 | $2.07B | Buy |
|
|||||
|
2017
Q3 | $2.41B | Buy |
|
|||||
|
2017
Q2 | $2.59B | Buy |
|
|||||
|
2017
Q1 | $1.98B | Buy |
|
|||||
|
2016
Q4 | $1.81B | Buy |
|
|||||
|
2016
Q3 | $1.93B | Buy |
|
|||||
|
2016
Q2 | $1.67B | Buy |
|
|||||
|
2016
Q1 | $1.69B | Buy |
|
|||||
|
2015
Q4 | $2.47B | Buy |
|
|||||
|
2015
Q3 | $2.06B | Buy |
|
|||||
|
2015
Q2 | $2.19B | Buy |
|
|||||
|
2015
Q1 | $1.89B | Buy |
|
|||||
|
2014
Q4 | $1.65B | Buy |
|
|||||
|
2014
Q3 | $1.39B | Sell |
|
|||||
|
2014
Q2 | $1.11B | Sell |
|
|||||
|
2014
Q1 | $1.18B | Buy |
|
|||||
|
2013
Q4 | $1.04B | Buy |
|
|||||
|
2013
Q3 | $1.16B | Sell |
|
|||||
|
2013
Q2 | $962M | Buy |
|